Company facts
- Headquarters
- Oakville
- Most recent report
- 6-K, filed Nov 3, 2026
- Incorporated
- N/A
- Filings on record
- 188 filings
- On EDGAR
- CIK 1702123
- Fiscal year ends
- December
- Filer status
- Emerging growth company
Financials 8 of 138
- 6-K Report a foreign issuer made public elsewhere Nov 3, 2026
- 6-K Report a foreign issuer made public elsewhere Nov 3, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 23, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 16, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 15, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 11, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 10, 2026
- 6-K Report a foreign issuer made public elsewhere Sep 9, 2026
Prospectuses and Registrations 3
Ownership 8 of 10
- SCHEDULE 13G/A Large holder reported a passive stake, amended Sep 23, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended May 15, 2026
- SCHEDULE 13G Large holder reported a passive stake Jan 30, 2026
- SCHEDULE 13G Large holder reported a passive stake Oct 23, 2025
- SC 13G/A Large holder reported a passive stake, amended Nov 6, 2024
- SC 13G/A Large holder reported a passive stake, amended Feb 13, 2024
- SC 13G/A Large holder reported a passive stake, amended Feb 14, 2023
Other 8 of 37
Everything here comes from Cardiol Therapeutics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.